Evidence map

ReviewHuman cell2025

The "dual personality" of LOXL3: a tumor accomplice and a new hope for immunotherapy.

Shuang Wu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 41219639